Document is current
Any future updates will be listed below
-
Authors
Chung, Claire S.
Kherallah, Kenan
Fragoso, Natalie M.
Daveluy, Steven
Hsiao, Jennifer L.
Lee, Katrina H.
-
Funding
Funding for this research was provided by:
University of Southern California
- License Information
-
More Information
Article History
Received: 20 October 2025
Accepted: 29 October 2025
First Online: 3 December 2025
Declarations
:
: NMF has served as a consultant for UCB, and as an investigator for Amgen, Abbvie, Acelyrin, Boehringer Ingelheim, Insmed, Takeda, and Target Derm. SD is on the board of directors for the HS Foundation, and has served as advisor, investigator, and/or speaker for Abbvie, Novartis, UCB, Incyte, Moonlake, Pfizer, Sanofi, Regeneron, Insmed. JLH is on the board of directors for the HS Foundation, and has served as an advisor, investigator, and/or speaker for AbbVie, Aclaris, Amgen, AstraZeneca, Boehringer Ingelheim, Galderma, Incyte, Navigator Medicines, Novartis, Pfizer, Regeneron, Sanofi, UCB. KHL has served as an advisor and/or investigator for Novartis, Incyte. The other authors report no disclosures.
: The authors declare no competing interests.
